- Home
- CNTA vs TTMI Comparison
CNTA vs TTMI Comparison
Compare CNTA & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- TTMI
- Stock Information
- Founded
- CNTA 2020
- TTMI 1978
- Country
- CNTA United Kingdom
- TTMI United States
- Employees
- CNTA N/A
- TTMI N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- TTMI Electrical Products
- Sector
- CNTA Health Care
- TTMI Technology
- Exchange
- CNTA Nasdaq
- TTMI Nasdaq
- Market Cap
- CNTA 2.2B
- TTMI 2.3B
- IPO Year
- CNTA 2021
- TTMI 2000
- Fundamental
- Price
- CNTA $14.59
- TTMI $20.86
- Analyst Decision
- CNTA Strong Buy
- TTMI Strong Buy
- Analyst Count
- CNTA 8
- TTMI 5
- Target Price
- CNTA $23.86
- TTMI $28.25
- AVG Volume (30 Days)
- CNTA 1.1M
- TTMI 686.5K
- Earning Date
- CNTA 03-24-2025
- TTMI 04-30-2025
- Dividend Yield
- CNTA N/A
- TTMI N/A
- EPS Growth
- CNTA N/A
- TTMI N/A
- EPS
- CNTA N/A
- TTMI 0.54
- Revenue
- CNTA N/A
- TTMI $2,442,753,000.00
- Revenue This Year
- CNTA N/A
- TTMI $8.07
- Revenue Next Year
- CNTA N/A
- TTMI $4.39
- P/E Ratio
- CNTA N/A
- TTMI $39.89
- Revenue Growth
- CNTA N/A
- TTMI 9.41
- 52 Week Low
- CNTA $7.75
- TTMI $13.43
- 52 Week High
- CNTA $19.09
- TTMI $30.41
- Technical
- Relative Strength Index (RSI)
- CNTA 38.85
- TTMI 34.52
- Support Level
- CNTA $13.78
- TTMI $21.92
- Resistance Level
- CNTA $16.87
- TTMI $23.47
- Average True Range (ATR)
- CNTA 1.07
- TTMI 0.75
- MACD
- CNTA -0.23
- TTMI -0.01
- Stochastic Oscillator
- CNTA 19.33
- TTMI 8.74
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.